Suppr超能文献

忍冬提取物:通过多细胞类型调节治疗特应性皮炎的有前途的治疗选择。

Forsythia velutina Nakai extract: A promising therapeutic option for atopic dermatitis through multiple cell type modulation.

机构信息

Natural Product Research Center, Korea Institute of Science and Technology (KIST), Gangneung, Korea.

Division of Bio-Medical Science & Technology, University of Science and Technology (UST), Daejeon, Korea.

出版信息

Allergy. 2024 May;79(5):1242-1257. doi: 10.1111/all.15967. Epub 2023 Dec 1.

Abstract

BACKGROUND

Atopic dermatitis (AD) is a complex condition characterized by impaired epithelial barriers and dysregulated immune cells. In this study, we demonstrated Forsythia velutina Nakai extract (FVE) simultaneously inhibits basophils, macrophages, keratinocytes, and T cells that are closely interrelated in AD development.

METHODS

We analyzed the effect of FVE on nitric oxide and reactive oxygen species (ROS) production in macrophages, basophil degranulation, T cell activation, and tight junctions in damaged keratinocytes. Expression of cell-type-specific inflammatory mediators was analyzed, and the underlying signaling pathways for anti-inflammatory effects of FVE were investigated. The anti-inflammatory effects of FVE were validated using a DNCB-induced mouse model of AD. Anti-inflammatory activity of compounds isolated from FVE was validated in each immune cell type.

RESULTS

FVE downregulated the expression of inflammatory mediators and ROS production in macrophages through TLR4 and NRF2 pathways modulation. It significantly reduced basophil degranulation and expression of type 2 (T2) and pro-inflammatory cytokines by perturbing FcεRI signaling. Forsythia velutina Nakai extract also robustly inhibited the expression of T2 cytokines in activated T cells. Furthermore, FVE upregulated the expression of tight junction molecules in damaged keratinocytes and downregulated leukocyte attractants, as well as IL-33, an inducer of T2 inflammation. In the AD mouse model, FVE showed superior improvement in inflammatory cell infiltration and skin structure integrity compared to dexamethasone. Dimatairesinol, a lignan dimer, was identified as the most potent anti-inflammatory FVE compound.

CONCLUSION

Forsythia velutina Nakai extract and its constituent compounds demonstrate promising efficacy as a therapeutic option for prolonged AD treatment by independently inhibiting various cell types associated with AD and disrupting the deleterious link between them.

摘要

背景

特应性皮炎(AD)是一种复杂的疾病,其特征为上皮屏障受损和免疫细胞失调。在这项研究中,我们证明了连翘提取物(FVE)可同时抑制与 AD 发展密切相关的嗜碱性粒细胞、巨噬细胞、角质形成细胞和 T 细胞。

方法

我们分析了 FVE 对巨噬细胞中一氧化氮和活性氧(ROS)产生、嗜碱性粒细胞脱颗粒、T 细胞活化以及受损角质形成细胞中紧密连接的影响。分析了细胞类型特异性炎症介质的表达,并研究了 FVE 抗炎作用的潜在信号通路。使用 DNCB 诱导的 AD 小鼠模型验证了 FVE 的抗炎作用。在每种免疫细胞类型中验证了从 FVE 中分离的化合物的抗炎活性。

结果

FVE 通过 TLR4 和 NRF2 通路的调节下调了巨噬细胞中炎症介质的表达和 ROS 的产生。它通过干扰 FcεRI 信号显著减少了嗜碱性粒细胞脱颗粒和 2 型(T2)和促炎细胞因子的表达。连翘提取物还强烈抑制了活化 T 细胞中 T2 细胞因子的表达。此外,FVE 上调了受损角质形成细胞中紧密连接分子的表达,并下调了白细胞趋化因子以及 IL-33,这是 T2 炎症的诱导剂。在 AD 小鼠模型中,FVE 显示出优于地塞米松的改善炎症细胞浸润和皮肤结构完整性的效果。双氢马桑毒素,一种木脂素二聚体,被鉴定为最有效的 FVE 抗炎化合物。

结论

连翘提取物及其组成化合物通过独立抑制与 AD 相关的各种细胞类型并破坏它们之间的有害联系,为 AD 的长期治疗提供了有希望的治疗选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验